Foghorn Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
21.25
|
|
Average Rating
|
4.17
|
|
# Strong Buys
|
2
|
|
# Buys
|
3
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.77
|
0.00
|
0.77
|
100.00%
|
|
2022-12-31
|
-0.60
|
0.00
|
0.60
|
100.00%
|
|
2022-09-30
|
-0.62
|
-0.62
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.59
|
-0.66
|
-0.07
|
-11.86%
|
|
2022-03-31
|
-0.52
|
-0.65
|
-0.13
|
-25.00%
|
|
2021-12-31
|
-0.49
|
-0.77
|
-0.28
|
-57.14%
|
|
2021-09-30
|
-0.67
|
-0.71
|
-0.04
|
-5.97%
|
|
2021-06-30
|
-0.63
|
-0.63
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.93
|
|
2021-12-31
|
-2.73
|
|
2020-12-31
|
-6.27
|